Related Experiment Video

Updated: Aug 7, 2026

Neuro-rehabilitation Approach for Sudden Sensorineural Hearing Loss
09:44

Neuro-rehabilitation Approach for Sudden Sensorineural Hearing Loss

Published on: January 25, 2016

The role of corticosteroid therapy in children with pneumococcal meningitis

W A Kennedy1, M J Hoyt, G H McCracken

  • 1Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas 75235-9063.

American Journal of Diseases of Children (1960)
|December 11, 1991
PubMed

Insights

Corticosteroid therapy, particularly dexamethasone, may improve outcomes for infants and children with pneumococcal meningitis. Steroid treatment was linked to fewer long-term neurologic issues and better stability during initial treatment.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Neurology

Background:

  • Pneumococcal meningitis is a serious infection in infants and children.
  • Corticosteroid therapy has shown benefits in Haemophilus meningitis.
  • The efficacy of corticosteroids in pneumococcal meningitis requires further investigation.

Purpose of the Study:

  • To determine if corticosteroid therapy improves outcomes in pediatric pneumococcal meningitis.
  • To compare disease outcomes between steroid-treated and non-steroid-treated patients.

Main Methods:

  • Retrospective review of 97 infants and children with pneumococcal meningitis treated between 1984 and 1990.
  • Analysis of demographic and clinical characteristics, treatment regimens, and short-term and long-term outcomes.
  • Comparison of outcomes between patients receiving corticosteroid therapy (primarily dexamethasone) and those who did not.

Main Results:

  • No significant differences in initial clinical characteristics or early complications (seizures, effusions, hydrocephalus, positive CSF cultures) between groups.
  • Steroid therapy given before or concurrently with antibiotics reduced neurologic and cardiovascular instability post-antibiotic administration (0/30 vs 16/52).
  • Significantly fewer steroid-treated survivors experienced adverse long-term neurologic outcomes, including hearing impairment (4/35 vs 14/43).

Conclusions:

  • Corticosteroid therapy appears beneficial in managing pediatric pneumococcal meningitis.
  • Early administration of steroids with antibiotics may prevent acute complications.
  • Steroids are associated with improved long-term neurologic outcomes in survivors of pneumococcal meningitis.

More Related Videos

Intratracheal Instillation of Stem Cells in Term Neonatal Rats04:27

Intratracheal Instillation of Stem Cells in Term Neonatal Rats

Published on: May 4, 2020

Related Concept Videos

COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...